Tabish Saifee

Register now for this annual course: Neurology 2026: leading edge neurology for the practising clinician: 11-12th June 2026 designed for all levels in neurology and other neuroscience specialties: ucl.ac.uk/brain-sciences… @TabishSaifee

Preparing for PACES? The Queen Square Neurology PACES course on Saturday 24th January 2026 #MRCPUK uclhcharitycourses.com/courses/mrcp-p…

Register now for "Neurology 2025: leading edge neurology for the practising clinician"@UCLIoN on 10-11th June 2025: designed for consultants and trainees at all levels in neurology and other neuroscience specialties, from the UK, Europe and worldwide ucl.ac.uk/ion/study/neur…

ucl.ac.uk/ion/events/202… Anyone training for MRCP PACES and daunted by neurology - the Neurology Queen Square course is restarting this year after a COVID pause. Super patients/signs and very experienced neurology consultant trainers to take participants around. Highly recommended

Are you taking PACES? @MRCPUK . Join us for the popular Queen Square Neurology PACES course Saturday 10th May. #PACES #MRCP. Register here uclhcharitycourses.com/courses/mrcp-p….

10th annual @UCLIoN neurology course is this June. Book your place now. ucl.ac.uk/ion/neurology-…

Register now for this annual course: Neurology 2025: leading edge neurology for the practising clinician: 10th-11th June 2025: a fantastic line up of speakers on topics from neurogenetics to neuroradiology, and neurotoxicology to migraine treatment. ucl.ac.uk/ion/neurology-…

Queen Square Neurology #PACES course for those preparing for the #MRCP #UCLH uclhcharitycourses.com/courses/mrcp-p…

There are 2 types of Parkinson's disease based on classical anatomy-clinical methods, the first is James Parkinson's shaking palsy and the second also described here is what I have called the other Parkinson's disease academic.oup.com/brain/article/…

@DrPujaMehta1 @DrNeenaJha @DrSelvarajah @michael_zandi Sorry, meant under-served!

@DrPujaMehta1 @DrNeenaJha @DrSelvarajah @michael_zandi So sorry to hear. Such an undeserved part of our healthcare

@ajlees This opinion piece warns of possible inadvertent worsening of cardiometabolic risk when taking such a glucocentric view of nutrition wchh.onlinelibrary.wiley.com/doi/full/10.10…

The kindling of health anxiety is highly profitable. For a healthy person to be monitoring 24 hour glucose is a ridiculous waste of money that should never be funded by the NHS. Next will be a MoCa or MMS administered daily with the amyloid test once a year. Call it out #Zoe

A great line-up of key opinion leaders from the worlds of #MultipleSclerosis, #neuroimaging, neuro-ophthalmology, #vestibular disorders, channelopathies, #sleep disorders and #neurosurgery coming to speak at ucl.ac.uk/ion/neurology-….

Following diagnosis, the treatment of #EssentialTremor is multimodal, where medication, occupational therapy and surgery may have a role to play. In this video, @TabishSaifee discusses the treatments currently available: 🎬 - eu1.hubs.ly/H06-K970 @NatTremor

One of the very few films of founder member of the @movedisorder Dean of @UCLIoN and charismatic and mercurial teacher David Marsden my colleague and supporter. Still sorely missed @kailashbhatia

@QueenSquareFUS @INSIGHTEC @RoySocMed Thanks for the invite to speak @RoySocMed about #tremor and its medical management. Interesting neuroimaging talk from Amir Zand and the role of functional Neurosurgery presented by my good colleague, Jonathan Hyam.

It was a pleasure to exhibit alongside @INSIGHTEC at @RoySocMed on Tuesday for the Intrusive Neurological Conditions conference on #essential tremor and #facialpain. #QueenSquare was well represented, with excellent presentations from @TabishSaifee and Mr Jonathan Hyam.

Honoured to have moderated the excellent session on neuroimaging of #tremor. Uniting Neurophysiology and imaging; great talks from Dr Aparna Shukla, Dr Daniel Claassen, Dr Rick Helmich at the International Tremor Congress.

@rimonaweil Well done Rimona!

So excited to be awarded a Career Development Award to understand dementia in Parkinson’s - I will be combining MRI with measures of protein accumulation and working with fantastic colleagues - thank you for this amazing opportunity!

Lilly’s Alzheimer’s drug donanemab succeeds in PhIII trial – 35% slowing of decline in those with intermediate tau levels on both iADRS and CDRSB. Really exciting news for our patients. Details will be shared at AAIC #alzheimers #diseasemodification endpts.com/lillys-alzheim…

Excellent, well led Jonathan.